ALGM ALLEGRO MICROSYSTEMS, INC.
Semiconductors & Related Devices · Nasdaq · SEC CIK 866291 · Fiscal year ends 03/31
Financial factors as of 2026-09-25 (2027Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY27.9%
TTM net income YoY209.1%
TTM EPS YoY206.2%
Revenue 3-yr CAGR-2.0%
Net income 3-yr CAGR-50.4%
Margins
Gross margin47.9%
Operating margin7.5%
Net margin3.1%
FCF margin10.4%
EBITDA margin13.0%
Returns
ROE3.2%
ROA2.2%
ROIC (approx.)5.0%
Asset turnover0.71x
Leverage & solvency
Liabilities / assets30.6%
Debt / equity0.29x
Current ratio4.13x
Interest coverage4.02x
Cash quality & payout
Operating cash flow / net income4.52x
Accruals ratio-7.7%
Payout ratio—
Capex / revenue3.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-03-27 | FY20252025-03-28 |
|---|---|---|
| Income statement | ||
| Revenue | $890.10M | $725.01M |
| Cost of revenue | $478.13M | $403.48M |
| Gross profit | $411.97M | $321.53M |
| R&D expense | $205.80M | $179.65M |
| SG&A expense | $181.09M | $161.68M |
| Operating income | $18.49M | -$19.80M |
| Interest expense | $22.14M | $30.37M |
| Pretax income | -$14.90M | -$85.70M |
| Income tax | -$248,000 | -$12.93M |
| Net income | -$14.90M | -$73.01M |
| EBITDA | $86.08M | $44.70M |
| EPS (basic) | -0.08 | -0.39 |
| EPS (diluted) | -0.08 | -0.39 |
| Weighted avg. shares (diluted) | 185.04M | 187.71M |
| Balance sheet | ||
| Cash & equivalents | $168.75M | $131.11M |
| Receivables | $93.25M | $84.60M |
| Inventory | $181.75M | $183.91M |
| Current assets | $503.61M | $483.04M |
| PP&E, net | $308.26M | $302.92M |
| Goodwill | $203.29M | $202.47M |
| Intangibles | $238.68M | $262.12M |
| Total assets | $1.42B | $1.42B |
| Current liabilities | $145.93M | $112.26M |
| Short-term debt | $1.53M | $1.42M |
| Long-term debt | $285.75M | $344.70M |
| Total debt | $287.28M | $346.13M |
| Total liabilities | $459.73M | $489.86M |
| Shareholders' equity | $954.75M | $929.55M |
| Net debt | $118.52M | $215.02M |
| Shares outstanding | 185.36M | 184.29M |
| Cash flow statement | ||
| Operating cash flow | $163.07M | $61.91M |
| Capital expenditure | $38.18M | $39.95M |
| Free cash flow | $124.89M | $21.96M |
| Investing cash flow | -$41.72M | -$40.82M |
| Financing cash flow | -$77.38M | -$112.06M |
| Depreciation & amortization | $67.59M | $64.50M |
| Stock-based compensation | $47.91M | $41.87M |
| Share buybacks | $0 | $853.92M |
Free plan shows the latest 2 periods; Pro shows all 8 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.